Zydus unit gets 10 observations from USFDA after inspection
The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.
Zydus Lifesciences said US health regulator has issued ten observations after inspecting its injectable manufacturing plant (File Image)
Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in Gujarat.
The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.
You’ve Read Your Free Stories For Now
Sign up and keep reading more stories that matter to you.
